Literature DB >> 15015359

[Effects of one Chinese herbs on improving cognitive function and memory of Alzheimer's disease mouse models].

Hua Sun1, Yu Hu, Jian-min Zhang, Shi-you Li, Wei He.   

Abstract

OBJECTIVE: To investigate Chinese herbs with the effect on significantly improving the cognitive function and retention of patients with Alzheimer's disease.
METHOD: AD mouse models were established by injecting poly-beta-AP25-35 into the cerebral ventricle of mice. The curative effects of traditional Chinese herbs Dangguishaoyaosan, Chaihujialonggumulitang and two herbs (CHP I and CHP II) developed by the authors on improving the memory and cognitive function of AD mouse models were studied by the detection of behavioral and histochemical tests, with piracetam serving as control. RESULT: CHP II has profound curative effects on improving the memory and cognitive function of AD-like animal model.
CONCLUSION: The present study indicates that it has a satisfactory prospect to seek new drugs from Chinese herbs to treat AD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15015359

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Krill-Derived Phosphatidylserine Improves TMT-Induced Memory Impairment in the Rat.

Authors:  Hyun Soo Shim; Hyun-Jung Park; Yong Ho Ahn; Song Her; Jeong-Jun Han; Dae-Hyun Hahm; Hyejung Lee; Insop Shim
Journal:  Biomol Ther (Seoul)       Date:  2012-03       Impact factor: 4.634

2.  Neuroprotective Effect of Lucium chinense Fruit on Trimethyltin-Induced Learning and Memory Deficits in the Rats.

Authors:  Hyun-Jung Park; Hyun Soo Shim; Woong Ki Choi; Kyung Soo Kim; Hyunsu Bae; Insop Shim
Journal:  Exp Neurobiol       Date:  2011-09-20       Impact factor: 3.261

3.  Chronic Treatment with Squid Phosphatidylserine Activates Glucose Uptake and Ameliorates TMT-Induced Cognitive Deficit in Rats via Activation of Cholinergic Systems.

Authors:  Hyun-Jung Park; Seung Youn Lee; Hyun Soo Shim; Jin Su Kim; Kyung Soo Kim; Insop Shim
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-22       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.